Products

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

China API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib, Find details about China Acalabrutinib, Acalabrutinib Powder from API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

Model NO.
Condavo-Acalabrutinib
Name
Acalabrutinib
Product Name
Acalabrutinib Powder
Einecs
814-272-0
Appearance
White Powder
Color
White Color
Test Method
HPLC UV
Storage
Cool Dry Place
Shelf Life
2 Years
Assay
99%
Grade
Medicine Grade
COA
Available
CAS
1420477-60-6
Mf
C26h23n7o2
MW
465.517
Density
1.37
Trademark
Condavo
Transport Package
1kg/ Aluminium Bag or 25kg/Drum; as Required
Specification
99%
Origin
Shaanxi
Model NO.
Condavo-Acalabrutinib
Name
Acalabrutinib
Product Name
Acalabrutinib Powder
Einecs
814-272-0
Appearance
White Powder
Color
White Color
Test Method
HPLC UV
Storage
Cool Dry Place
Shelf Life
2 Years
Assay
99%
Grade
Medicine Grade
COA
Available
CAS
1420477-60-6
Mf
C26h23n7o2
MW
465.517
Density
1.37
Trademark
Condavo
Transport Package
1kg/ Aluminium Bag or 25kg/Drum; as Required
Specification
99%
Origin
Shaanxi
API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib
API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib
Product Description

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical AcalabrutinibAPI CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

Product NameAcalabrutinib
CAS1420477-60-6
AppearanceWhite crystalline powder
MFC26H23N7O2
MW465.517
Purity99%
Shelf Life2 Years
Acalabrutinib(ACP-196) is a selective second-generation BTK inhibitor that inhibits the activation of B cell surface protoantibody signaling pathways. It has good target specificity and is 323-,94-,19-,9- times more selective for BTK than other TEC kinase family members such as ITK, TXK, BMK and TEC. No activity for EGFChemicalbookR.
Sample Display

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

Function & Application

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical AcalabrutinibACP-196 is an investigational anticancer drug that is a selective Bruton tyrosine kinase (BTK) inhibitor. This kinase transmits signals from the B cell receptor (BCR), so any inherited BTK mutation causes B cell immune deficiency. Therefore, BTK inhibitors targeting B cell signaling have shown great promise in the treatment of chronic lymphocytic leukemia (CLL).
API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

It is a new oral cancer cell inhibitor for the treatment of NSCLC, breast cancer and gastric cancer, and has a targeted tyrosine kinase small molecule inhibitor.
Specification

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical AcalabrutinibAPI CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

Packaging & Shipping

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

Certifications

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

Our Team

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

About Us

API CAS 1420477-60-6 Acalabrutinib Chemical Acalabrutinib Pharmaceutical Acalabrutinib

 

You Might Also Like